Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Fox

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parametersM Dybul, T W Chun, C Yoder, et al.
The Journal of Clinical Investigation|September 18, 1997
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressorsO J Cohen, M Vaccarezza, G K Lam, et al.
Advances in Dental Research|May 25, 2010
Proceedings: 9th World Congress on Preventive Dentistry (WCPD): "Community Participation and Global Alliances for Lifelong Oral Health for All," Phuket, Thailand, September 7-10, 2009J Clarkson, R G Watt, A J Rugg-Gunn, et al.
Journal of Dental Research|June 16, 2026
Advancing a Global Oral Health Research AgendaL D Rock, S M Balaji, H Benzian, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parametersM Dybul, T W Chun, C Yoder, et al.
The Journal of Clinical Investigation|September 18, 1997
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressorsO J Cohen, M Vaccarezza, G K Lam, et al.
Advances in Dental Research|May 25, 2010
Proceedings: 9th World Congress on Preventive Dentistry (WCPD): "Community Participation and Global Alliances for Lifelong Oral Health for All," Phuket, Thailand, September 7-10, 2009J Clarkson, R G Watt, A J Rugg-Gunn, et al.
Journal of Dental Research|June 16, 2026
Advancing a Global Oral Health Research AgendaL D Rock, S M Balaji, H Benzian, et al.
Pageof 16